Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hassel

Showing results (91-100 of 322) with videos related to

Pageof 33
Sort By:
Cancers|April 3, 2021
Quantitative Dynamic <sup>18</sup>F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 InhibitorsChristos Sachpekidis, Jessica C Hassel, Annette Kopp-Schneider, et al.
Cancer Immunology, Immunotherapy : CII|November 28, 2018
Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?Christos Sachpekidis, Lionel Larribère, Annette Kopp-Schneider, et al.
Future Oncology (London, England)|February 17, 2015
Histogram analysis of iodine maps from dual energy computed tomography for monitoring targeted therapy of melanoma patientsMonika Uhrig, David Simons, Maria-Katharina Ganten, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2018
Rituximab as a therapeutic option for patients with advanced melanomaJulia K Winkler, Matthias Schiller, Carolin Bender, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
The prognostic value of [<sup>18</sup>F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteriaChristos Sachpekidis, Vivienn Weru, Annette Kopp-Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2026
Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CTLeyun Pan, Christos Sachpekidis, Dimitrios S Strauss, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2022
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapyMartin Salzmann, Klaus Hess, Kristin Lang, et al.
Der Radiologe|July 22, 2017
[Malignant melanoma : Current status]J K Winkler, K Buder-Bakhaya, A Dimitrakopoulou-Strauss, et al.
Journal of Nanoscience and Nanotechnology|December 8, 2010
Magnetism of single-crystalline Fe nanostructuresJ Lindner, C Hassel, A V Trunova, et al.
The Journal of Prosthetic Dentistry|February 12, 2008
Predicting tooth color from facial features and gender: results from a white elderly cohortAlexander J Hassel, Ina Nitschke, Jens Dreyhaupt, et al.
Pageof 33

Showing results (91-100 of 322) with videos related to

Sort By:
Pageof 33
Cancers|April 3, 2021
Quantitative Dynamic <sup>18</sup>F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 InhibitorsChristos Sachpekidis, Jessica C Hassel, Annette Kopp-Schneider, et al.
Cancer Immunology, Immunotherapy : CII|November 28, 2018
Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?Christos Sachpekidis, Lionel Larribère, Annette Kopp-Schneider, et al.
Future Oncology (London, England)|February 17, 2015
Histogram analysis of iodine maps from dual energy computed tomography for monitoring targeted therapy of melanoma patientsMonika Uhrig, David Simons, Maria-Katharina Ganten, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2018
Rituximab as a therapeutic option for patients with advanced melanomaJulia K Winkler, Matthias Schiller, Carolin Bender, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2023
The prognostic value of [<sup>18</sup>F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteriaChristos Sachpekidis, Vivienn Weru, Annette Kopp-Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2026
Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CTLeyun Pan, Christos Sachpekidis, Dimitrios S Strauss, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2022
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapyMartin Salzmann, Klaus Hess, Kristin Lang, et al.
Der Radiologe|July 22, 2017
[Malignant melanoma : Current status]J K Winkler, K Buder-Bakhaya, A Dimitrakopoulou-Strauss, et al.
Journal of Nanoscience and Nanotechnology|December 8, 2010
Magnetism of single-crystalline Fe nanostructuresJ Lindner, C Hassel, A V Trunova, et al.
The Journal of Prosthetic Dentistry|February 12, 2008
Predicting tooth color from facial features and gender: results from a white elderly cohortAlexander J Hassel, Ina Nitschke, Jens Dreyhaupt, et al.
Pageof 33